Clin2
NCT03966170Possibly a fitRecruiting

CitiColine to help protect the brain in preterm babies

Pre-Term

Part of Women’s health & pregnancy clinical trials.

This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
40 people
Ages
Up to 1 month
Study type
Interventional

Who can take part

  • Your baby was born preterm (early)
  • Your baby needs breathing support using CPAP or a ventilator
  • Your baby does not have multiple birth defects (multiple congenital anomalies)
  • Your baby’s care team determines they can safely take part in the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03949049Recruiting· Phase 3
Citi-coline for babies who had low oxygen at birth

This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.

Cairo
NCT06522581Recruiting· Phase 1
Citicoline for brain injury in newborns

This trial tests if citicoline, a brain-protecting supplement, can help newborns with moderate to severe brain injury from lack of oxygen. It is for babies who have not gotten cooling treatment.

Rawalpindi
NCT07763145Not yet recruiting
Citicoline for newborns with birth oxygen loss

This trial tests whether a medicine called citicoline can help newborns who had a brief lack of oxygen around birth, which can affect their brain. It aims to see if the medicine improves their recovery and brain blood flow.

Peshawar, KPK
NCT06972849Not yet recruiting
Caffeine for very preterm babies to improve outcomes

This trial tests whether giving caffeine citrate early to very preterm babies (born before 32 weeks) can improve their breathing and overall health. It's for babies who need caffeine anyway as part of their care, and it looks at short- and long-term benefits.

NCT07456670Not yet recruiting· Phase 2
Caffeine for preterm infants needing breathing support

This study is testing whether giving caffeine to babies born a few weeks early helps them breathe better and reduce time on breathing support. It includes babies who need a breathing tube or other breathing help soon after birth.

Kingston, Ontario
NCT05907317Recruiting· Phase 3
Protecting the brains of very young newborns on breathing machines

This Phase 3 study tests ways to protect brain health in newborns who are very premature or recently born and need a breathing machine through a tube. It may help reduce the risk of brain injury while they receive intensive care.

Madrid

Hear when a new Pre-Term trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.